Discover our range of treatment options. A detailed overview of anika therapeutics, inc On october 31, 2025, anika submitted the third and final module of its hyalofast pma to the u.s Food and drug administration (fda) Third quarter 2025 results anika reported third quarter revenue from continuing operations of $27.8 million, a 6% decrease compared to the same period in 2024. In arabic, anika (arabic writing
It is a variant of aniqa (arabic writing أنيقة) which means neat, elegant, unique or “smart. Anika (anik) delivered earnings and revenue surprises of +100.00% and +0.06%, respectively, for the quarter ended september 2025 Do the numbers hold clues to what lies ahead for the stock? We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, and regenerative solutions Since our incorporation in 1992, anika has evolved into a market leader in joint preservation.
[2][3] before she began her singing career, anika worked as a music promoter in cardiff and political journalist in berlin Founded in 1992, anika has global expertise developing and manufacturing products in early intervention orthopedic care.
WATCH
